Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases
Frontiers in Physiology · 28.08.2025 · 16
DOI: 10.3389/fphys.2025.1641323 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 28.08.2025. Verfasst von Muhammad S Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Ferroptosis is an iron-dependent programmed cell death that plays an important role in neurodegenerative and neuropsychiatric diseases. In the present study, we have highlighted how different risk factors are involved in the induction of ferroptosis in brain cells. In addition, we also demonstrated how ferroptosis plays an important role in different brain diseases. In our study why we focused and elaborated on the mechanisms of ferroptosis only in brain cells (Neurons, oligodendrocytes, and microglia) because they are particularly vulnerable to such kind of cell death. Additionally, brain cells are more dependent on mitochondrial function, iron regulation, and high levels of polyunsaturated fatty acids (PUFAs) as compared to peripheral body cells. Highlighting ferroptosis is more important because it has demonstrated several important mechanisms of neuronal injury and dysfunction which provides a deep understanding of the etiology of various brain diseases that were not sufficiently described by other programmed cell death pathways. Therefore, it has led to the exploration of new therapeutic strategies against various brain diseases and thus targeting ferroptosis-related proteins opens a new therapeutic window for several incurable brain diseases, and various ferroptosis regulators are now under clinical trials. However, their validation as a preclinical therapeutic agent is needed. Interestingly, here in our study we also summarize the most recent potential therapeutic targets and promising interventions which will provide a beam of light for future therapies against major brain diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
- Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Khan, M. S., Hu, Q., Okeibunor, K., Ma, L., & Bopassa, J. C. (2025). Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases. Frontiers in Physiology, 16. https://doi.org/10.3389/fphys.2025.1641323
Vancouver
Khan MS, Hu Q, Okeibunor K, Ma L, Bopassa JC. Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases. Frontiers in Physiology. 2025;16. doi:10.3389/fphys.2025.1641323
BibTeX
@article{Khan2025,
author = {Khan, Muhammad S and Hu, Qichan and Okeibunor, Kendrix and Ma, Liang and Bopassa, Jean C},
title = {Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases},
journal = {Frontiers in Physiology},
year = {2025},
volume = {16},
doi = {10.3389/fphys.2025.1641323}
}
EUVIMED